Jennifer E Hibma (Jennifer Hibma)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Combination Therapy

Duchenne Muscular Dystrophy

Top Venues

Clinical and translational science

CPT: pharmacometrics & systems pharmacology

Cancer chemotherapy and pharmacology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Jennifer E Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O Harnisch
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy. CPT: pharmacometrics & systems pharmacology (2023)
Jennifer E Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O Harnisch
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Jennifer E Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O Harnisch
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Jennifer E Hibma, Melissa O'Gorman, Sunil Nepal, Sylvester Pawlak, Katherine Ginman, Yazdi K Pithavala
Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants. Cancer chemotherapy and pharmacology (2021)
Jennifer E Hibma, Beverly Knight
Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia. Clinical pharmacokinetics 58 (3) (2020)